<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-156268</identifier>
<setSpec>1575-0922</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO)</dc:title>
<dc:description xml:lang="en">Objective. The aim of this study was to detect people at risk of suffering diabetes or changes in carbohydrate metabolism and to refer them for possible diagnosis to health care centres. The number of diagnoses and costs for the pharmacy were recorded. Methods. A cross-sectional, observational study was conducted in community pharmacies in Pontevedra in September-October of 2014. The Findrisc questionnaire was completed by pharmacy users over 18 years old. If Findrisc score was &amp;#8805; 15, capillary blood glucose was measured, and the participant was referred to a physician if the value was &amp;#8805; 110mg/dL. The main variables included score in the Findrisc questionnaire, number of diabetes diagnosed, and cost of the service. Differences between the groups were calculated using a Chi-squared test, a Student's t test, and/or a Wilcoxon test. Results. This study was conducted in 180 pharmacies on a sample of 4,222 users, including 992 (23.5%) with a high or very high risk of diabetes (F&amp;#8805;15). In the 1,060 basal capillary blood glucose tests performed, mean glucose level was 110.2 (SD=20.4)mg/dL (56&#150;254). The Galician Health Service sent information about 83 of the 384 (9.1%) subjects referred to a physician: 28 (33.7%) of them were diagnosed with diabetes (3.1% of the sample), and 26 (31.3%) were diagnosed with prediabetes (2.8% of the sample). Cost per diagnosed subject was &#128; 184.22 per subject with diabetes and &#128; 96.86 per subject with prediabetes. Conclusions. The proportion of subjects with new diagnosis of diabetes (3.1%) shows the high efficiency of a screening program for hidden diabetics implemented at community pharmacies as the one presented here (AU)</dc:description>
<dc:creator>Andrés-Iglesias, J Carlos</dc:creator>
<dc:creator>Luna-Cano, Reyes</dc:creator>
<dc:creator>Floro Andrés-Rodríguez, N</dc:creator>
<dc:creator>García-Riestra, Rosario</dc:creator>
<dc:creator>García-Soidán, Javier</dc:creator>
<dc:creator>Lorenzo-Veiga, Blanca</dc:creator>
<dc:creator>Fornos-Pérez, José Antonio</dc:creator>
<dc:creator>Mera-Gallego, Rocío</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Pilotar una actividad profesional consistente en la detección de personas en riesgo de padecer diabetes o alteraciones del metabolismo de los hidratos de carbono y derivación para posible diagnóstico en los centros de salud. Comprobación del número de diagnósticos y evaluación del coste para la farmacia. Métodos. Estudio observacional transversal en farmacias comunitarias de Pontevedra en septiembre-octubre de 2014. Cuestionario Findrisc a usuarios de la farmacia con más de 18 años. Con Findrisc &amp;#8805; 15 determinación de la glucemia basal capilar y derivación al médico con &amp;#8805; 110mg/dL. Variables principales: puntos en cuestionario Findrisc, número de diagnósticos de diabetes, coste del servicio. Las diferencias entre grupos se calcularon con el test de chi-cuadrado, t de Student o test de Wilcoxon. Resultados. El estudio se realizó en 180 farmacias. La muestra incluyó a 4.222 usuarios. De ellos, 992 (23,5%) tenían alto o muy alto riesgo de diabetes (F&amp;#8805;15). Se realizaron 1.060 test de glucemia basal capilar, con un resultado medio de 110,2 (DE=20,4)mg/dL (56-254). De los 384 (9,1%) sujetos derivados al médico, el Servicio Gallego de Salud envió información de 83: 28 (33,7%) diagnosticados de diabetes (3,1% de la muestra) y 26 (31,3%) de prediabetes (2,8%). El coste por sujeto diagnosticado fue de 184,22 &#128; y por sujeto con diabetes o prediabetes fue de 96,86 &#128;. Conclusiones. El número de diagnósticos de nuevos pacientes diabéticos, 3,1% de la muestra total, muestra la alta eficiencia de un programa de cribado para diabéticos ocultos realizado en farmacias comunitarias como el que aquí se presenta (AU)</dc:description>
<dc:source>Endocrinol Nutr;63(8): 387-396, oct. 2016. tab, gra</dc:source>
<dc:identifier>ibc-156268</dc:identifier>
<dc:title xml:lang="es">Detección de personas en riesgo de padecer diabetes en farmacias comunitarias de Pontevedra (DEDIPO)</dc:title>
<dc:subject>^d3942^s22080</dc:subject>
<dc:subject>^d25123^s22045</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d38340</dc:subject>
<dc:subject>^d1812^s22002</dc:subject>
<dc:subject>^d4258^s22080</dc:subject>
<dc:subject>^d3189^s22083</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d37656</dc:subject>
<dc:type>article</dc:type>
<dc:date>201610</dc:date>
</metadata>
</record>
</ibecs-document>
